Skip to main content
FinSpry Logo
FinSpry
GMAB logo
GMAB
(NASDAQ)
Genmab A/S
$33.02-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Genmab A/S (GMAB) Stock Price & Financial Analysis

Genmab A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$32.74 - $33.32
52-Week High$35.43
52-Week Low$23.62
Open$32.82
Volume3.25M
Average Volume (3M)2.44M
Market Cap21.09B
Shares Outstanding638.55M
P/E Ratio (TTM)25.54
Forward P/E33.81
Price to Sales (P/S)5.37
Price to Book (P/B)3.69
EV/EBITDA21.40
Revenue (TTM)3.90B
Net Income (TTM)821.20M
Free Cash Flow (TTM)871.99M
EPS (TTM)$1.28
Profit Margin21.03%
Operating Margin32.98%
Return on Equity (ROE)14.45%
Debt to Equity0.94
50-Day MA$28.07
200-Day MA$29.04
52-Week Change40.88%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Genmab A/S

What is the current stock price for GMAB?

As of the latest trading session, GMAB stock trades at $33.02. The 52-week range is $23.62–$35.43, with a day range of $32.74–$33.32.

What is the P/E ratio for GMAB?

Genmab A/S's trailing P/E ratio is 25.5, meaning investors pay $25.5 for every $1 of annual earnings. The forward P/E is 33.8, reflecting analyst expectations for future earnings. Genmab A/S operates in the Healthcare sector.

Does GMAB pay dividends?

Genmab A/S does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GMAB?

Based on 9 analysts, the consensus for GMAB is Buy.

What is the market cap of GMAB?

Genmab A/S's market capitalization is $21.09B, classifying it as a large-cap company. Genmab A/S operates in the Healthcare sector within the Biotechnology industry.